BRCA1 and RAD51C gene promoter methylation patterns predict response to PARP inhibitor therapy in High Grade Serous Ovarian Carcinoma
Welcome to the Walter and Eliza Hall Institute of Medical Research
With the NDDC researchers have access to advanced high-throughput screening and the latest robotic technologies in a fully staffed facility.
Apply for an Australian government-subsidised screening campaign, and fast track your discoveries into new medicines.
Walter and Eliza Hall Institute researchers have won a $3.5 million ACRF grant to conquer the biggest challenges in cancer today – predicting and improving patients’ treatment response and overcoming drug resistance.
Professor David Vaux AO and Professor Andreas Strasser have been jointly awarded the 2019 CSL Florey Medal for establishing a new field of research – the molecular biology of programmed cell death.
Cancer researcher Dr Tracy Putoczki has won a five-year, $1.25 million Viertel Fellowship to study how communication between tumours and their environment helps cancers grow and spread.
A discovery about how the immune system responds to malaria infection could lead to better treatments for hepatitis C, HIV and lupus, say Melbourne researchers.
BRCA1 and RAD51C gene promoter methylation patterns predict response to PARP inhibitor therapy in High Grade Serous Ovarian Carcinoma
Could microbes be the cause of Alzheimer's disease?
Death Becomes Them: latently infected cells & their retroviruses
Identifying and overcoming therapeutic resistance in high-risk acute lymphoblastic leukaemia
Empty